Delivery Order SPE2DX15D3003-SPE2DX24F5P0M

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $2.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The firm-fixed price Delivery Order contract, valued at $1,464.64, was awarded by the Defense Agency Defense Logistics Agency Troop Support Medical on May 6, 2024 with a completion date of May 7, 2024. This award is not set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The contract, valued at $3,217.58, was awarded on July 3, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical with an ultimate completion date of July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Lantus SoloStar 100 unit/mL 3mL medical supplies. The $1,598.96 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of November 7, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,821.14 firm fixed price delivery order is for 4566054659 LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication product. The contract has an ultimate completion date of October 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lantus Solostar 100 unit/mL 3mL pharmaceutical supplies. The contract has a ceiling value of $1,360.01 and a completion date of July 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,187.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563667526 ! LANTUS SOLOSTAR 100 UNIT/ML 3ML. This contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, with a potential value of $2,764.86. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for $1,190.10 to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $1,157.91 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, is...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,163.18 and was awarded on May 20, 2024, with a completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
  • SPE2DX15D3003
    Indefinite Delivery Contract
  • SPE2DX15D3003-SPE2DX24F5P0M
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Firm Fixed Price Delivery Order contract valued at $2,890.59. The contract is to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML to the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 10/11/24, 9:20 AM